225 related articles for article (PubMed ID: 17653593)
1. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
4. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
5. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
Bonatz G; Frahm SO; Klapper W; Helfenstein A; Heidorn K; Jonat W; Krupp G; Parwaresch R; Rudolph P
Hum Pathol; 2001 Jun; 32(6):605-14. PubMed ID: 11431715
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and telomerase activity in extra-abdominal desmoid tumors.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Ochi M
Anticancer Res; 2007; 27(1A):411-5. PubMed ID: 17352261
[TBL] [Abstract][Full Text] [Related]
8. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Hsu CP; Miaw J; Shai SE; Chen CY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in ovarian tumors.
Murakami J; Nagai N; Ohama K; Tahara H; Ide T
Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
Wu K; Lund M; Bang K; Thestrup-Pedersen K
Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer.
Hirashima T; Komiya T; Nitta T; Takada Y; Kobayashi M; Masuda N; Matui K; Takada M; Kikui M; Yasumitu T; Ohno A; Nakagawa K; Fukuoka M; Kawase I
Anticancer Res; 2000; 20(3B):2181-7. PubMed ID: 10928174
[TBL] [Abstract][Full Text] [Related]
15. Telomeric associations correlate with telomere length reduction and clonal chromosome aberrations in giant cell tumor of bone.
Gebre-Medhin S; Broberg K; Jonson T; Gorunova L; von Steyern FV; Brosjö O; Jin Y; Gisselsson D; Panagopoulos I; Mandahl N; Mertens F
Cytogenet Genome Res; 2009; 124(2):121-7. PubMed ID: 19420923
[TBL] [Abstract][Full Text] [Related]
16. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H
Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168
[TBL] [Abstract][Full Text] [Related]
17. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
19. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
Gertler R; Doll D; Maak M; Feith M; Rosenberg R
Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
[TBL] [Abstract][Full Text] [Related]
20. Primary malignant giant-cell tumor of bone has high survival rate.
Domovitov SV; Healey JH
Ann Surg Oncol; 2010 Mar; 17(3):694-701. PubMed ID: 19902306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
